Topical neurokinin-1 receptor antagonism ameliorates ocular pain and prevents corneal nerve degeneration in an animal model of dry eye disease
Abstract. Introduction:. Ocular pain is a common complaint to eye care providers, associated with a variety of ocular conditions, among which dry eye disease (DED) is affecting millions of people worldwide. Despite being highly prevalent, ocular pain is not managed adequately in the clinic. Objectiv...
Saved in:
Main Authors: | Amirreza Naderi, Yukako Taketani, Shudan Wang, Francesca Kahale, Ann Yung, Pier Luigi Surico, Yihe Chen, Reza Dana |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2025-02-01
|
Series: | PAIN Reports |
Online Access: | http://journals.lww.com/painrpts/fulltext/10.1097/PR9.0000000000001232 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neurokinin-1 Receptor Antagonist Treatment in Polymicrobial Sepsis: Molecular Insights
by: Akhil Hegde, et al.
Published: (2010-01-01) -
The Role of Neurokinin-1 Receptor in the Microenvironment of Inflammation and Cancer
by: Marisa Rosso, et al.
Published: (2012-01-01) -
Beyond incretins: targeting neurokinin receptors for obesity treatment
by: Doreen Thor, et al.
Published: (2025-01-01) -
Inhibition of Corneal Neovascularization by Topical and Subconjunctival Tigecycline
by: Sertan Goktas, et al.
Published: (2014-01-01) -
Ocular Surface Temperature in Age-Related Macular Degeneration
by: Andrea Sodi, et al.
Published: (2014-01-01)